Dengue Virus Serotype 2 Established in Northern Mozambique (2015-2016)

Am J Trop Med Hyg. 2017 Nov;97(5):1418-1422. doi: 10.4269/ajtmh.17-0317. Epub 2017 Oct 10.


After the report of an outbreak of dengue virus serotype 2 in 2014 in Nampula and Pemba cities, northern Mozambique, a surveillance system was established by the National Institute of Health. A study was performed during 2015-2016 to monitor the trend of the outbreak and confirm the circulating serotype of dengue virus (DENV). After the inclusion of consenting patients who met the case definition, samples from 192 patients were tested for the presence of nonstructural protein 1 antigen, and 60/192 (31%) samples were positive. Further analysis included DENV IgM antibodies, with 39 (20%) IgM positive cases. Reverse transcriptase (RT) PCR was performed for identification of the prevailing DENV serotype; 21/23 tested samples were DENV-2 positive, with DENV-2 present in both affected cities. When sequencing DENV, phenotype Cosmopolitan was identified. The surveillance indicates ongoing spread of DENV-2 in northern Mozambique 2 years after the first report of the outbreak.

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Cross-Sectional Studies
  • Dengue / epidemiology*
  • Dengue Virus / classification
  • Dengue Virus / genetics*
  • Dengue Virus / isolation & purification*
  • Disease Outbreaks
  • Female
  • Humans
  • Immunoglobulin M / blood
  • Male
  • Mozambique / epidemiology
  • Phylogeny
  • Serogroup
  • Viral Nonstructural Proteins / genetics*
  • Young Adult


  • Antibodies, Viral
  • Immunoglobulin M
  • Viral Nonstructural Proteins